Comparison of two ready-to-use systems specially designed for physiological intracytoplasmic sperm injection (ICSI): PICSI® versus Sperm Slow™, a prospective randomised trial

Not Applicable

Completed

• Conditions: Intracytoplasmic sperm injection (ICSI); Pregnancy and Childbirth; Fertility

• Registration Number: ISRCTN72668039
• Lead Sponsor: GynePro Medical Centers (Italy)

Brief Summary

2012 results in https://pubmed.ncbi.nlm.nih.gov/22749221/ (added 18/12/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-10-11
• Study Completion: 2011-03-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Infertile women not older than 41 years undergoing ICSI treatment at GynePro Medical Center
2. Semen parameters of the male partner:
2.1. Presence of ejaculate motile spermatozoa with total sperm number greater than or equal to 1,000,000
2.2. Sperm motility greater than or equal to 5%

Exclusion Criteria

1. Women older than 41 years old
2. Patients with male partners with testicular spermatozoa or severe oligoastenoteratozoospermia (total sperm number less than 1,000,000 and sperm motility less than 5%)

Study & Design

• Study Type: Interventional
• Study Design: Not specified